Found 11 matching trials
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma PHASE2 This phase II randomized trial compares the efficacy and safety of Toripali...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial
Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma PHASE2 The aim of this study is to define whether combination of induction chemoth...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer PHASE3 This prospective study aims to investigate whether the time of day when imm...
Show More Location
Hunna Cancer Hospital, Clinical Trails Center
Learn More & Join Trial
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial PHASE2 For stage III non-small cell lung cancer (NSCLC), neoadjuvant chemotherapy ...
Show More Location
Multiple Locations
Learn More & Join Trial
Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC PHASE2 In recent years, immune checkpoint inhibitors targeting cytotoxic T-lymphoc...
Show More Location
The Fourth Military Medical University Tangdu Hospital
Learn More & Join Trial
FMD and Neoadjuvant Chemo-immunotherapy in TNBC PHASE2 The primary objective of this study is to investigate the efficacy and safe...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Probiotics in Advanced Urothelial Carcinoma PHASE2 This is a multicenter, randomized, controlled phase II Study of evaluating ...
Show More Location
Sun yat-sen university cancer center
Learn More & Join Trial
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study N/A Esophageal squamous cell carcinoma (ESCC) is highly prevalent in China, wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLC PHASE2 The aim of the study was to investigate the efficacy of Toripalimab Combine...
Show More Location
Hunan Provincal Tumor Hospital
Learn More & Join Trial